Bridge Creek Capital Management LLC Has $3.26 Million Holdings in Medtronic plc (NYSE:MDT)
Bridge Creek Capital Management LLC raised its holdings in shares of Medtronic plc (NYSE:MDT – Free Report) by 0.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 40,847 shares of the medical technology company’s stock after acquiring an […]
Bridge Creek Capital Management LLC Has $3.26 Million Holdings in Medtronic plc (NYSE:MDT)
Bridge Creek Capital Management LLC raised its holdings in shares of Medtronic plc (NYSE:MDT – Free Report) by 0.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 40,847 shares of the medical technology company’s stock after acquiring an […]
Leave a Reply
More Stories
241 Shares in NVR, Inc. (NYSE:NVR) Bought by Miracle Mile Advisors LLC
Miracle Mile Advisors LLC bought a new position in shares of NVR, Inc. (NYSE:NVR – Free Report) in the 4th...
Eastern Bank Makes New $68,000 Investment in UDR, Inc. (NYSE:UDR)
Eastern Bank acquired a new stake in shares of UDR, Inc. (NYSE:UDR – Free Report) in the fourth quarter, HoldingsChannel.com...
Brokerages Set George Weston Limited (TSE:WN) Target Price at C$248.75
George Weston Limited (TSE:WN – Get Free Report) has received a consensus rating of “Moderate Buy” from the six brokerages...
SLM (NASDAQ:SLM) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says
SLM (NASDAQ:SLM – Free Report) had its price objective lifted by JPMorgan Chase & Co. from $27.00 to $29.00 in...
Tactile Systems Technology (NASDAQ: TCMD) Appoints Laura G. King to Board of Directors
Tactile Systems Technology, Inc. recently announced the election of Laura G. King to its board of directors on January 10,...
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Receives “Outperform” Rating from Wedbush
Kiniksa Pharmaceuticals (NASDAQ:KNSA – Get Free Report)‘s stock had its “outperform” rating reaffirmed by Wedbush in a research report issued...